Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shibuya

Showing results (431-440 of 463) with videos related to

Pageof 47
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 1998
Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosisY Horita, M Miyazaki, T Koji, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2002
The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancerT Matsumoto, Y Ohashi, S Morita, et al.
British Journal of Cancer|May 5, 2005
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)Y Kokubo, A Gemma, R Noro, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Phase I/II pharmacokinetic and pharmacogenomic study of UGT1A1 polymorphism in elderly patients with advanced non-small cell lung cancer treated with irinotecanN Yamamoto, T Takahashi, H Kunikane, et al.
Kidney International|April 28, 2006
Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritisA Hara, T Wada, K Furuichi, et al.
Journal of Neuroimmunology|July 1, 1993
Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomasC J Wikstrand, S D Stanley, P A Humphrey, et al.
Cell Structure and Function|December 1, 1990
Nonlethal G0-ts mutant tsJT60 becomes lethal at the nonpermissive temperature after transformation: a hint for new cancer chemotherapeuticsY Y Tai, J Ninomiya-Tsuji, K Furuoku, et al.
No to Shinkei = Brain and Nerve|March 28, 2001
[A case of central nervous system anomalies (agenesis of corpus callosum, colpocephaly, hydrocephalus, congenital dermal sinus) associated with congenital heart disease(double-outlet right ventricle, complete endocardial cushion defect, atrial septal defect, pulmonary arterial stenosis, patent ductus arteriosus)]H Oyama, A Numaguchi, H Sakurai, et al.
British Journal of Cancer|August 1, 1982
Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lungN Saijo, E Shimizu, M Shibuya, et al.
Chemical & Pharmaceutical Bulletin|August 3, 2000
Chalcone and stilbene synthases expressed in eucaryotes exhibit reduced cross-reactivity in vitroD Y Suh, J Kagami, K Fukuma, et al.
Pageof 47

Showing results (431-440 of 463) with videos related to

Sort By:
Pageof 47
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 1998
Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosisY Horita, M Miyazaki, T Koji, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 13, 2002
The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancerT Matsumoto, Y Ohashi, S Morita, et al.
British Journal of Cancer|May 5, 2005
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)Y Kokubo, A Gemma, R Noro, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Phase I/II pharmacokinetic and pharmacogenomic study of UGT1A1 polymorphism in elderly patients with advanced non-small cell lung cancer treated with irinotecanN Yamamoto, T Takahashi, H Kunikane, et al.
Kidney International|April 28, 2006
Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritisA Hara, T Wada, K Furuichi, et al.
Journal of Neuroimmunology|July 1, 1993
Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomasC J Wikstrand, S D Stanley, P A Humphrey, et al.
Cell Structure and Function|December 1, 1990
Nonlethal G0-ts mutant tsJT60 becomes lethal at the nonpermissive temperature after transformation: a hint for new cancer chemotherapeuticsY Y Tai, J Ninomiya-Tsuji, K Furuoku, et al.
No to Shinkei = Brain and Nerve|March 28, 2001
[A case of central nervous system anomalies (agenesis of corpus callosum, colpocephaly, hydrocephalus, congenital dermal sinus) associated with congenital heart disease(double-outlet right ventricle, complete endocardial cushion defect, atrial septal defect, pulmonary arterial stenosis, patent ductus arteriosus)]H Oyama, A Numaguchi, H Sakurai, et al.
British Journal of Cancer|August 1, 1982
Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lungN Saijo, E Shimizu, M Shibuya, et al.
Chemical & Pharmaceutical Bulletin|August 3, 2000
Chalcone and stilbene synthases expressed in eucaryotes exhibit reduced cross-reactivity in vitroD Y Suh, J Kagami, K Fukuma, et al.
Pageof 47